Optimal antimicrobial catheter lock solution, using different combinations of minocycline, EDTA, and 25-percent ethanol, rapidly eradicates organisms embedded in biofilm.
about
Antifungal lock therapyAntibiotic lock therapy: review of technique and logistical challengesToluidine blue-mediated photodynamic effects on staphylococcal biofilmsShear stress modulates the thickness and architecture of Candida albicans biofilms in a phase-dependent mannerClinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of AmericaRhodococcus bacteremia in cancer patients is mostly catheter related and associated with biofilm formation.Efficacy of calcium-EDTA as an inhibitor for metallo-β-lactamase in a mouse model of Pseudomonas aeruginosa pneumonia.Green biocides, a promising technology: current and future applications to industry and industrial processes.Ethanol lock therapy (E-Lock) in the prevention of catheter-related bloodstream infections (CR-BSI) after major heart surgery (MHS): a randomized clinical trialNew materials and devices for preventing catheter-related infections.Ethanol and Isopropyl Alcohol Exposure Increases Biofilm Formation in Staphylococcus aureus and Staphylococcus epidermidis.In vitro efficacy of daptomycin and teicoplanin combined with ethanol, clarithromycin or gentamicin as catheter lock solutions.Central venous catheter-associated Nocardia bacteremia in cancer patients.Efficacy of ethanol locks in reducing central venous catheter infections in pediatric patients with intestinal failureFungal Biofilms: In Vivo Models for Discovery of Anti-Biofilm DrugsChelator-based catheter lock solutions in eradicating organisms in biofilmEfficacy of ethanol against Candida albicans and Staphylococcus aureus polymicrobial biofilms.The Role of Antifungals against Candida Biofilm in Catheter-Related Candidemia.Reduced biocide susceptibility in Candida albicans biofilmsTreatment strategies for central venous catheter infections.Ethanol lock technique: review of the literature.Biofilm elimination on intravascular catheters: important considerations for the infectious disease practitioner.Rescue therapy of difficult-to-treat indwelling central venous catheter-related bacteremias in cancer patients: a review for practical purposes.Antibiofilm agents and implant-related infections in orthopaedics: where are we?Bench-to-bedside review: Challenges of diagnosis, care and prevention of central catheter-related bloodstream infections in childrenFuture directions for anti-biofilm therapeutics targeting Candida.Future therapies targeted towards eliminating Candida biofilms and associated infections.Advances in the treatment of problematic industrial biofilms.Successful Salvage of Central Venous Catheters in Patients with Catheter-Related or Central Line-Associated Bloodstream Infections by Using a Catheter Lock Solution Consisting of Minocycline, EDTA, and 25% Ethanol.Effect of chitosan-ethylenediamine tetraacetic acid on Enterococcus faecalis dentinal biofilm and smear layer removal.Full and broad-spectrum in vivo eradication of catheter-associated biofilms using gentamicin-EDTA antibiotic lock therapy.Efficacy of Ethanol against Trichosporon asahii Biofilm in vitro.Caprylic acid and glyceryl trinitrate combination for eradication of biofilm.EDTA inhibits biofilm formation, extracellular vesicular secretion, and shedding of the capsular polysaccharide glucuronoxylomannan by Cryptococcus neoformans.In vitro analyses of ethanol activity against Candida albicans biofilms.Chitosan-EDTA new combination is a promising candidate for treatment of bacterial and fungal infections.Efficacy of acidic and basic electrolyzed water in eradicating Staphylococcus aureus biofilm.Activity of novel antibiotic lock solutions in a model against isolates of catheter-related bloodstream infections.Investigation of the effects of various antibiotics against Klebsiella pneumoniae biofilms on in vitro catheter model.Activity of Amphotericin B and Anidulafungin Combined with Rifampicin, Clarithromycin, Ethylenediaminetetraacetic Acid, N-Acetylcysteine, and Farnesol against Candida tropicalis Biofilms.
P2860
Q27025682-B9D7B13C-1ACB-420A-864F-1FA63DFF991CQ28082777-643B5DCC-4391-4485-92BC-DA7B77768B7CQ33304273-B2B37B3E-D552-48D7-B3D4-32EDE6D9D2B8Q33392309-070037CE-FE9C-4206-8B04-1077D327E7B1Q33688646-B7AB0DB7-E023-4866-9E8F-F255D0C3F707Q34200198-76DC5688-35A6-4766-9280-C49297BB0B17Q34290145-F0C28341-1180-49CA-8DFD-81DF63F81D0BQ34975378-9E503480-809F-4002-BDED-205034D27AFDQ35133595-4F12F8E8-8D77-48CA-8F15-73B30865E2C5Q35207061-48DD2094-CC8C-446C-8537-08CF178CA6F0Q35752751-8C403BAC-E857-4D8F-8F3F-80F8865C9EBCQ35827920-2E00AF56-0639-467C-B3EB-AA213975AF3EQ35877503-DBF2F1BB-30F2-41D7-B705-FD42711A5FE7Q35991290-EB0191D1-AA16-4FBF-A69B-2C672A575479Q36089061-84772586-B15B-4987-91D8-78CEF262CABBQ36505410-772BCD79-446E-4773-B40D-B5D7B60AB813Q36505589-5F652736-241C-418C-B0B9-4CAB7049407BQ36683547-05A0845A-0833-423B-9F1E-216785C724CAQ36870880-B7FECA11-3860-4B93-BBE6-4DCED514BA68Q37596412-C9FDECCF-797B-4890-9031-B2C70DEC70C7Q37608324-72A34BD6-369B-486E-8294-8DECEC940C2AQ37860818-50650B74-AA0A-4325-B671-883FD02FFAA8Q38081494-CD58DC7C-45B2-428D-93C2-4CF9A788DC3EQ38107655-0F382EC1-CC3B-4579-A520-1C9E2B41159AQ38138178-AB6B5E8C-69A7-4DE5-B6C6-39C15FDA4D4DQ38186068-E2C54130-F7A1-4886-8869-42CB4BA92531Q38786061-A20DE64D-1895-4068-8C54-F516DE426F12Q39242503-0C26AE05-4F66-403D-85BE-45A428F2EE22Q40113033-01581A11-3247-4F5B-A712-59FA1B6A3AFFQ40531415-44F4DF59-CF3A-4EBC-AC8E-E96E54C89FCBQ41182648-94167A2C-077D-40D3-BC86-88FC64771F88Q41349073-B76E29F2-809E-4653-BF4A-0E2D3E34071CQ41585405-F6A516C7-30F7-4896-9D62-6787BD3C8826Q41588074-4F12EB64-49BE-4F14-B77E-E1615DD2DDD8Q42280850-981EECFF-3CA2-4F37-9A2B-EE1A9A9811E1Q42852118-4DDE4AD6-63F0-47A6-B71A-C74ADBF25D4AQ44522479-D659F8D4-2B67-4DCF-8F21-DEDB8FA1969FQ45226443-41D005C5-9194-45F9-B40C-B6B4FDE6B1D7Q48139465-FC18E378-13B8-4C62-A6F6-4D0FABA2A44AQ48523183-05DCBC12-AEDB-4CF5-89D4-0977F2913009
P2860
Optimal antimicrobial catheter lock solution, using different combinations of minocycline, EDTA, and 25-percent ethanol, rapidly eradicates organisms embedded in biofilm.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Optimal antimicrobial catheter ...... organisms embedded in biofilm.
@en
Optimal antimicrobial catheter ...... organisms embedded in biofilm.
@nl
type
label
Optimal antimicrobial catheter ...... organisms embedded in biofilm.
@en
Optimal antimicrobial catheter ...... organisms embedded in biofilm.
@nl
prefLabel
Optimal antimicrobial catheter ...... organisms embedded in biofilm.
@en
Optimal antimicrobial catheter ...... organisms embedded in biofilm.
@nl
P2093
P2860
P356
P1476
Optimal antimicrobial catheter ...... organisms embedded in biofilm.
@en
P2093
Gassan Chaiban
Hend Hanna
Issam Raad
Ray Hachem
Tanya Dvorak
P2860
P356
10.1128/AAC.00154-06
P407
P577
2006-10-30T00:00:00Z